Navigation Links
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
Date:5/17/2012

or in the absence of resuscitative equipment.
  • NUCYNTA® ER is contraindicated in any patient who has or is suspected of having a paralytic ileus.
  • NUCYNTA® ER is contraindicated in patients who are receiving monoamine oxidase inhibitors (MAOIs) or who have taken them within the last 14 days due to potential additive effects on norepinephrine levels, which may result in adverse cardiovascular events.
  • NUCYNTA® ER is contraindicated in patients with a known hypersensitivity to the active substance, tapentadol, or any component of the product. Angioedema has been reported in association with use of tapentadol.

    • WARNINGS & PRECAUTIONS

    • NUCYNTA® ER tablets are to be swallowed whole and are not to be split, broken, chewed, dissolved, or crushed. Taking split, broken, chewed, crushed, or dissolved NUCYNTA® ER tablets leads to the rapid release and absorption of a potentially fatal dose of tapentadol. 
    • NUCYNTA® ER tablets must be kept in a secure place out of the reach of children. Accidental consumption of NUCYNTA® ER, especially in children, can result in a fatal overdose of tapentadol.
    • Respiratory depression is the primary risk of mu-opioid agonists. Respiratory depression occurs more frequently in elderly or debilitated patients and in those suffering from conditions accompanied by hypoxia, hypercapnia, or upper airway obstruction, in whom even moderate therapeutic doses may significantly decrease pulmonary ventilation.
    • Use NUCYNTA® ER with caution in patients with conditions accompanied by hypoxia, hypercapnia, or decreased respiratory reserve, such as: asthma, chronic obstructive pulmonary disease or cor pulmonale, severe obesity, sleep apnea syndrome, myxedema, kyphoscoliosis, central nervous system (CNS) dep
      '/>"/>

    SOURCE Janssen Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
    2. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
    3. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
    4. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
    5. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
    6. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
    7. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
    8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
    9. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
    10. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
    11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2013)... , May 21, 2013  Cephasonics, ... platform, today announced the introduction of the ... complete network-based communications with all cQuest Ultrasound™ ... embedded-ultrasound technology, including this new capability, at ... Paulo, Brazil from May 21-24.  ...
    (Date:5/21/2013)... 2013 iHealth Lab Inc., a pioneer ... healthcare products and a powerful integrated mobile app ... of two new fitness products to its existing ... the Wireless Pulse Oximeter and Wireless Activity and ... iHealth Lab is also excited ...
    (Date:5/21/2013)... Hurel Corporation ("Hurel"), a world-leading provider of ... today announced the appointment of James S. ... of Directors. Dr. MacDonald is the former Executive Vice ... ("SPRI"), which was the pharmaceutical development arm of Schering ... in 2009. Over a career that has ...
    Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
    ... Cardica, Inc. (Nasdaq: CRDC ) ... General Surgery at the Red Cross Hospital Clementinenhaus, ... laparoscopic procedures using Cardica,s, proprietary Microcutter XPRESS™ 30 ... several sigmoidectomies, an appendectomy and a small intestinal ...
    ... , For the fourth year, the Fondation,Médéric ... for evidence-based psychosocial,interventions for people with dementia and their ... care and share best,practices. Applications can be submitted from ... http://www.alz.co.uk/award . Psychosocial research involves or ...
    Cached Medicine Technology:Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device 2Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device 34th Alzheimer's Awards Announced in Search of Global Solutions for Better Dementia Care 2
    (Date:5/21/2013)... Nearly 40 Platinum Supplemental Insurance ... trip in Los Cabos, Mexico, Feb. 23-March 1, 2013, to ... elderly. , The facility serves meals and provides a social ... Cabo, Mexico. , Platinum Vice President, Mike Muench, says that ... company’s history. , “Platinum got its start selling long-term ...
    (Date:5/21/2013)... Dallas, Tx. (PRWEB) May 21, 2013 ... first peer- reviewed journal article testing the efficacy of ... symptoms of eczema. The clinical study results appear in ... , The article, “A Novel Sodium Hypochlorite Cleanser ... of Atopic Dermatitis,” reports impressive findings seen after consistent ...
    (Date:5/21/2013)... 21, 2013 Access MediQuip, LLC ... management company, announced today that it has expanded its ... the nation's largest health benefits companies, with more than ... approximately 66 million individuals served through its subsidiaries. , ... surgical implant management program agreement back in 2008. Under ...
    (Date:5/21/2013)... Everspark Interactive, one of the city's leading online ... the past year – and announced another milestone this ... efforts for Kids II, a designer of innovative baby ... local effort, specializing in search engine optimization (SEO) or ... website. The company now offers a host of boutique ...
    (Date:5/21/2013)... Dimensional Insight, a developer of business intelligence ... Maryland Health System, a 275-bed hospital based in ... to help it analyze its data more quickly. Western ... Diver through Dimensional Insight’s recently announced partnership with ... Maryland has massive amounts of data in disparate systems, ...
    Breaking Medicine News(10 mins):Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 2Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 3Health News:Everspark Named Interactive Marketing Company for Kids II 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3
    ... shown that people who exercise do better on memory ... does within the brain//. Exercise targets a region of ... gyrus, which underlies normal age-related memory decline that begins ... is significant because it was accomplished via the first-ever ...
    ... of Leicester and Ferrara in Italy have developed a potential ... benefits will be discussed at a public lecture on 20th ... in the development the drug in collaboration with Dr Girolamo ... UFP-101 - avoids many of the side effects of morphine, ...
    ... on the home PC is no longer a far fetched ... system, slated to span the whole of// England. The medical ... the quality of patient care, enabling access to personal medical ... about this plan will be sent to patients and they ...
    ... child’s race may be a factor in determining ... tobacco smoke (ETS). //The study reveals that African ... ETS, have significantly higher toxin levels when compared ... children suffer from higher rates of tobacco-related disorders, ...
    ... by an unintentional injury or new chronic condition, those without ... care and more likely to experience larger declines in short-term ... of the Urban Institute, Washington, D.C., presented the results of ... to care at the National Press Club. ,The ...
    ... dean of University of Massachusetts Medical School Dr. Aaron Lazare ... was reported that he has developed cardiac arrhythmia. ... and the private memorial health care. He has also set ... he joined UMass as a professor of psychiatry and chair ...
    Cached Medicine News:Health News:New Reason to Hit the Gym: Fighting Memory Loss 2Health News:Race Affects Tobacco Absorption in Children 2Health News:Uninsured Often Receive Less Medical Care 2
    Long-Sleeve Bolero for targeted compression in the upper arms, upper back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
    Velcro® closure, uniform contour compression, available as 9" and 12" bands for abdominal support, 9" can be used as a breast wrap....
    Sub Pectoral Breast Augmentation Wrap...
    CDIs Ultra-Comfort Bra™ is designed with special single needle stitching that places the cup seams away from critical surgical sites....
    Medicine Products: